SCOPUS 정보 검색 플랫폼

Epilepsy Research

Volumn 47, Issue 1-2, 2001, Pages 77-90

A systematic review of the safety profile of levetiracetam: A new antiepileptic drug

(3) French, Jacqueline a Edrich, Pascal b Cramer, Joyce A c

a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA (United States)

b UCB PHARMA (Belgium)

c YALE UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

Adverse effects; Antiepileptic drug; Epilepsy; Keppra ; Levetiracetam

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; HEMOGLOBIN; PLACEBO;

ADOLESCENT; ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; ASTHENIA; BEHAVIOR; BLOOD CELL COUNT; BLOOD LEVEL; CLINICAL TRIAL; COGNITION; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG PROGRAM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERANCE; EPILEPSY; ERYTHROCYTE; FEMALE; HEMATOCRIT; HUMAN; INCIDENCE; LABORATORY TEST; LEUKOCYTE; MAJOR CLINICAL STUDY; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION; VERTIGO;

ANTICONVULSANTS; CLINICAL TRIALS; EPILEPSY; PIRACETAM;

EID: 0034768383 PISSN: 09201211 EISSN: None Source Type: Journal
DOI: 10.1016/S0920-1211(01)00296-0 Document Type: Article

Times cited : (196)

References (16)

1
- 0002755154
- No occurrence of rebound phenomena after levetiracetam withdrawal or down titration
- abstract
- (2001) Epilepsia , vol.42 , Issue.2 , pp. 126
- Ben Menachem, E.¹

2
- 0033518849
- Postmarketing surveillance and adverse drug reactions: Current perspectives and future needs
- (1999) J. Am. Med. Assoc. , vol.281 , pp. 824-829
- Brewer, T.¹ Colditz, G.A.²

3
- 0032991290
- The Medical Dictionary for Regulatory Activities (MedRA)
- (1999) Drug Safety , vol.20 , pp. 109-117
- Brown, E.G.¹ Wood, L.² Wood, S.³

4
- 0032890949
- New antiepileptic drugs: Comparison of key clinical trials
- (1999) Epilepsia , vol.40 , pp. 590-600
- Cramer, J.A.¹ Fisher, R.² Ben Menachem, E.³ French, J.⁴ Mattson, R.H.⁵

5
- 0033934199
- Effect of levetiracetam on epilepsy-related quality of life
- (2000) Epilepsia , vol.41 , pp. 868-874
- Cramer, J.A.¹ Arrigo, C.² Van Hammee, G.³ Gauer, L.J.⁴ Cereghino, J.J.⁵

6
- 26344440085
- in review
- (2001) Treatment options for epilepsy: comparing new medications and vagal nerve stimulation
- Cramer, J.A.¹ Ben Menachem, E.² French, J.³

7
- 0003525258
- Department of Health and Human Services, Food and Drug Administration, Rockville, MD
- (1997) Coding Symbols for Thesaurus of Adverse Reaction Terms (COSTART)

8
- 0032608432
- The Med Watch Program
- (1999) J. Toxicol. Clin. Toxicol. , vol.37 , pp. 803-807
- Love, L.¹ Couig, M.D.²

9
- 0021887675
- Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic clonic seizures
- (1985) N. Engl. J. Med. , vol.313 , pp. 145-151
- Mattson, R.H.¹ Cramer, J.A.² Collins, J.F.³ Smith, D.B.⁴ Delgado-Escueta, A.V.⁵

10
- 0001299635
- Early tolerance to antiepileptic drug side effects: A controlled trial of 247 patients
- Frey, H.H., Koella, W.P. (Eds.). Raven Press, New York
- (1986) Tolerance to Beneficial and/or Adverse Effects of Antiepileptic Drugs, Recent Advances in Epilepsy , pp. 149-156
- Mattson, R.H.¹ Cramer, J.A.² Collins, J.F.³

11
- 0026794763
- A comparison of valproate with carbamazepine for the treatment of partial seizures and secondarily generalized tonic-clonic seizures in adults
- (1992) N. Engl. J. Med. , vol.327 , pp. 765-771
- Mattson, R.H.¹ Cramer, J.A.² Collins, J.F.³

12
- 0028932797
- Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy
- (1995) Prog. Neuro-Psychopharmacol. Biol. Psychiatry , vol.19 , pp. 411-419
- Neyens, L.G.J.¹ Alpherts, W.C.J.² Aldenkamp, A.P.³

13
- 0030833181
- A historical perspective on the mortality associated with chronic epilepsy
- (1997) Acta. Neurol. Scand. , vol.96 , pp. 138-141
- O'Donoghue, M.F.¹ Sander, J.W.A.S.²

14
- 0023127911
- Forced normalization: Acute psychosis after seizure control in seven patients
- (1987) Arch. Neurol. , vol.S44 , pp. 289-292
- Pakalnis, A.¹ Drake, M.E.² John, K.³ Kellum, J.B.⁴

15
- 0033883581
- Assessing risk to benefit ratio in antiepileptic drug therapy
- (2000) Epil. Res. , vol.41 , pp. 107-139
- Perucca, E.¹ Beghi, E.² Dulac, O.³ Shorvon, S.⁴ Tomson, T.⁵

16
- 0002750227
- Infections rates among patients participating in clinical trials
- (2000) Epilepsia , vol.41 , Issue.SUPPL. 7 , pp. 253
- Ting, T.¹ French, J.² Cramer, J.A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.